{"address1": "Emmy Noetherweg 2", "city": "Leiden", "zip": "2333 BK", "country": "Netherlands", "phone": "31 71 203 6410", "website": "https://pharvaris.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. The company operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.", "fullTimeEmployees": 92, "companyOfficers": [{"maxAge": 1, "name": "Mr. Berndt Axel Edvard Modig CPA, M.B.A.", "age": 65, "title": "Co-Founder, CEO & Executive Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 575518, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anna  Nijdam M.Sc., R.A.", "age": 43, "title": "Head of Strategic Finance & Principal Accounting Officer", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stefan  Abele Ph.D.", "age": 54, "title": "Chief Technology Operations Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Annick  Deschoolmeester", "age": 51, "title": "Chief Human Resources Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peng  Lu M.D., Ph.D.", "age": 46, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anne A. Lesage Ph.D.", "age": 63, "title": "Chief Early Development Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Wim  Souverijns Ph.D.", "age": 53, "title": "Chief Commercial Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David W. Nassif J.D.", "age": 70, "title": "CFO & Corporate Secretary", "yearBorn": 1954, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Maryann  Cimino", "title": "Director of Corporate Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 15.7, "open": 14.5, "dayLow": 14.5, "dayHigh": 15.46, "regularMarketPreviousClose": 15.7, "regularMarketOpen": 14.5, "regularMarketDayLow": 14.5, "regularMarketDayHigh": 15.46, "payoutRatio": 0.0, "beta": -3.015, "forwardPE": -4.862295, "volume": 42726, "regularMarketVolume": 42726, "averageVolume": 44345, "averageVolume10days": 22480, "averageDailyVolume10Day": 22480, "bid": 10.96, "ask": 19.12, "bidSize": 1, "askSize": 1, "marketCap": 804276864, "fiftyTwoWeekLow": 14.14, "fiftyTwoWeekHigh": 25.5, "fiftyDayAverage": 16.6233, "twoHundredDayAverage": 18.59205, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 499200768, "profitMargins": 0.0, "floatShares": 19153506, "sharesOutstanding": 54233100, "sharesShort": 577670, "sharesShortPriorMonth": 390943, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0107, "heldPercentInsiders": 0.09494001, "heldPercentInstitutions": 0.8948, "shortRatio": 11.11, "shortPercentOfFloat": 0.0139, "impliedSharesOutstanding": 54233100, "bookValue": 5.472, "priceToBook": 2.7101607, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -132208240, "trailingEps": -2.81, "forwardEps": -3.05, "enterpriseToEbitda": -3.905, "52WeekChange": -0.33467925, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 14.83, "targetHighPrice": 57.147026, "targetLowPrice": 14.347026, "targetMeanPrice": 36.679234, "targetMedianPrice": 33.98162, "recommendationMean": 1.71429, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 305193120, "totalCashPerShare": 5.627, "ebitda": -127851296, "totalDebt": 116939, "quickRatio": 18.809, "currentRatio": 19.075, "debtToEquity": 0.039, "returnOnAssets": -0.33102, "returnOnEquity": -0.5877, "freeCashflow": -62723008, "operatingCashflow": -108985408, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "EUR", "symbol": "PHVS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Pharvaris N.V.", "corporateActions": [], "preMarketTime": 1743582849, "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_402951024", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Pharvaris N.V.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "preMarketChange": 0.8100004, "preMarketChangePercent": 5.4619045, "preMarketPrice": 15.64, "regularMarketChange": -0.8699999, "regularMarketDayRange": "14.5 - 15.46", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 44345, "fiftyTwoWeekLowChange": 0.6899996, "fiftyTwoWeekLowChangePercent": 0.048797704, "fiftyTwoWeekRange": "14.14 - 25.5", "fiftyTwoWeekHighChange": -10.67, "fiftyTwoWeekHighChangePercent": -0.41843137, "fiftyTwoWeekChangePercent": -33.467926, "earningsTimestampStart": 1744142400, "earningsTimestampEnd": 1744660800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.81, "epsForward": -3.05, "epsCurrentYear": -2.6385, "priceEpsCurrentYear": -5.620618, "fiftyDayAverageChange": -1.7933006, "fiftyDayAverageChangePercent": -0.10787874, "twoHundredDayAverageChange": -3.7620506, "twoHundredDayAverageChangePercent": -0.20234726, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "prevName": "Pharvaris B.V.", "nameChangeDate": "2025-04-01", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "regularMarketChangePercent": -5.5414004, "regularMarketPrice": 14.83, "marketState": "PRE", "displayName": "Pharvaris", "trailingPegRatio": null}